Showing results (291-300 of 524) with videos related to
Sort By:
Pageof 53
Journal of Clinical Hypertension (Greenwich, Conn.)|March 18, 2015
Impact of Ambulatory Blood Pressure Monitoring on Reclassification of Hypertension Prevalence and Control in Older People in SpainJosé R Banegas, Juan J de la Cruz, Auxiliadora Graciani, et al.American Journal of Hypertension|October 10, 2002
Hypertension guidelines: criteria that might make them more clinically usefulMichael H Alderman, Curt D Furberg, John B Kostis, et al.Hypertension (Dallas, Tex. : 1979)|March 20, 2024
Prognostic Relevance of Short-Term Blood Pressure Variability. The Spanish ABPM RegistryAlejandro de la Sierra, Bryan Williams, Michael Bursztyn, et al.Diabetes, Obesity & Metabolism|August 24, 2018
Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective studyGian Paolo Fadini, Anna Solini, Maria Laura Manca, et al.The Journal of Clinical Endocrinology and Metabolism|November 20, 2008
1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parametersAngela Dardano, Simonetta Falzoni, Nadia Caraccio, et al.Hypertension (Dallas, Tex. : 1979)|March 30, 2011
Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoringAlejandro de la Sierra, Julián Segura, José R Banegas, et al.Antioxidants (Basel, Switzerland)|August 6, 2021
TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled HypertensionAranzazu Santiago-Hernandez, Marta Martin-Lorenzo, Ariadna Martin-Blazquez, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|February 19, 2016
Short-Term and Long-Term Reproducibility of Hypertension Phenotypes Obtained by Office and Ambulatory Blood Pressure MeasurementsAlejandro de la Sierra, Ernest Vinyoles, José R Banegas, et al.Nature Reviews. Cardiology|August 18, 2018
Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factorsCarmen Fiuza-Luces, Alejandro Santos-Lozano, Michael Joyner, et al.Acta Diabetologica|February 15, 2025
Different formulations of semaglutide and oxidative stress in subjects with type 2 diabetes and MASLD: an open-label, real-life studyGiovanni Petralli, Alice Del Zoppo, Chiara Rovera, et al.Pageof 53